This research will explore the pharmacology of flurazepan and other benzodiazepines as it relates to tolerance and dependence. We have shown that the central nervous system (CNS) is capable of a large, rapid adaptation to benzodiazepine exposure, even with rather low doses. Studies of receptor down-regulation have allowed some understanding of molecular mechanisms involved. Down-regulation of benzodiazepine receptors will be studied further using light microscopic autoradiography to localize sites of changes in receptor density. Previously, a correlation between receptor down-regulation and tolerance was found. Now, receptor regulation will be studied in animals treated with a method known to cause physical dependence to determine whether receptor regulation might contribute to dependence. Abstinence will be studied in withdrawing animals and in those given R015-1788, a benzodiazepine antagonist, to precipitate abstinence. Recent reports have shown that benzodiazepine receptors are present on pre- and postsynaptic neuronal membranes. Pre- and postsynaptic membrane enriched preparations will be used to determine if there is a selective pre- or postsynaptic localization of down-regulation. Possible involvement of receptors on adrenergic nerve terminals will be evaluated by studying the effects of intracerebroventricular 6-hydroxydopamine on subsequent receptor down-regulation, and on tolerance development. Drug effects on GABA-mediated C1- flux will also be studied in hippocampal slices that have been preloaded with radioactive chloride. Effects of benzodiazepines, Ro15-1788, and of pentobarbital will be studied to evaluate tolerance and dependence in this system. In behavioral studies, we will continue to study the dose and time requirements for producing physical dependence. Dependence due to flurazepam, diazepam and clonazepam will be compared. Because of the large autonomic component of precipitated abstinence, the effects of pretreatment with adrenergic blocking drugs, and changes in blood pressure and heart rate during abstinence will be studied. By using these various approaches, and comparing the results, we hope to continue to learn what mechanisms of adaptation are used by the CNS during chronic benzodiazepine exposure, and how these are manifest as tolerance and dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002194-08
Application #
3207171
Study Section
(DABA)
Project Start
1985-02-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Toledo
Department
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Dong, Yu; Rosenberg, Howard C (2004) Brief seizure activity alters Ca2+/calmodulin dependent protein kinase II dephosphorylation and subcellular distribution in rat brain for several hours. Neurosci Lett 357:95-8
Dong, Yu; Rosenberg, Howard C (2004) Prolonged changes in Ca2+/calmodulin-dependent protein kinase II after a brief pentylenetetrazol seizure; potential role in kindling. Epilepsy Res 58:107-17
Li, M; Szabo, A; Rosenberg, H C (2001) Evaluation of native GABA(A) receptors containing an alpha 5 subunit. Eur J Pharmacol 413:63-72
Li, M; Szabo, A; Rosenberg, H C (2000) Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region. J Pharmacol Exp Ther 295:689-96
Walsh, L A; Li, M; Zhao, T J et al. (1999) Acute pentylenetetrazol injection reduces rat GABAA receptor mRNA levels and GABA stimulation of benzodiazepine binding with No effect on benzodiazepine binding site density. J Pharmacol Exp Ther 289:1626-33
Zhao, T J; Li, M; Chiu, T H et al. (1998) Decreased benzodiazepine binding with little effect on gamma-aminobutyric acid binding in rat brain after treatment with antisense oligodeoxynucleotide to the gamma-aminobutyric acidA receptor gamma-2 subunit. J Pharmacol Exp Ther 287:752-9
Zhao, T J; Rosenberg, H C; Chiu, T H (1996) Treatment with an antisense oligodeoxynucleotide to the GABAA receptor gamma 2 subunit increases convulsive threshold for beta-CCM, a benzodiazepine ""inverse agonist', in rats. Eur J Pharmacol 306:61-6
Tersigni, T J; Rosenberg, H C (1996) Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA. Brain Res 733:184-92
Rosenberg, H C (1995) Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment. Pharmacol Biochem Behav 51:363-8
Wu, Y; Rosenberg, H C; Chiu, T H (1995) Rapid down-regulation of [3H]zolpidem binding to rat brain benzodiazepine receptors during flurazepam treatment. Eur J Pharmacol 278:125-32

Showing the most recent 10 out of 43 publications